Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Treace Medical Concepts, Inc.

Market Cap 267M 231M 212M 200M 375M 25.22B 378M 2.51B 978M 12.38B 1B 982M 42.83B P/E 2026 *
-4.58x
P/E 2027 * -4.93x
Enterprise Value 312M 269M 248M 233M 438M 29.48B 442M 2.94B 1.14B 14.47B 1.17B 1.15B 50.04B EV / Sales 2026 *
1.51x
EV / Sales 2027 * 1.6x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day+0.36%
1 week-1.54%
Current month+20.38%
1 month+51.45%
3 months+185.27%
6 months+61.43%
Current year+70.00%
1 week 3.76
Extreme 3.755
4.47
1 month 2.53
Extreme 2.53
4.47
Current year 1.17
Extreme 1.17
4.47
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
26
5 years 1.17
Extreme 1.17
35.09
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 30/06/2013
Director of Finance/CFO 56 31/08/2020
Chief Tech/Sci/R&D Officer - 28/02/2022
Director TitleAgeSince
Chairman 54 19/05/2025
Director/Board Member 64 19/11/2020
Director/Board Member 68 19/11/2020
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-1.54%-23.44%-83.89% 267M
-0.31%-0.54%+24.09%-5.97% 12.53B
+1.40%-3.68%+57.50%+25.60% 5.89B
-0.79%+1.68%+5.19%-8.66% 5.66B
+0.26%+0.92%-29.27%+16.32% 4.09B
0.00%-0.10% - - 4.13B
-0.86%+0.84%-29.30%-25.13% 3.76B
+2.74%+7.90%+3.07%-59.26% 2.03B
-0.66%+6.18%+46.94%+226.99% 1.83B
-0.17%0.00%+57.81%-5.06% 1.56B
Average +0.20%+1.01%+12.51%+8.99% 4.17B
Weighted average by Cap. +0.04%-0.78%+16.37%+7.01%

Financials

2026 *2027 *
Net sales 206M 178M 164M 154M 289M 19.47B 292M 1.94B 755M 9.55B 774M 758M 33.05B 222M 191M 176M 166M 311M 20.93B 314M 2.08B 812M 10.27B 833M 815M 35.54B
Net income -58.31M -50.3M -46.25M -43.53M -81.79M -5.5B -82.48M -548M -213M -2.7B -219M -214M -9.34B -54.66M -47.15M -43.35M -40.81M -76.68M -5.16B -77.32M -514M -200M -2.53B -205M -201M -8.76B
Net Debt 45.05M 38.87M 35.73M 33.63M 63.2M 4.25B 63.73M 423M 165M 2.09B 169M 165M 7.22B 88.04M 75.95M 69.83M 65.73M 124M 8.31B 125M 828M 322M 4.08B 330M 323M 14.11B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
17/06/26 4.165 $ +1.09% 225,115
16/06/26 4.120 $ +5.10% 795,529
15/06/26 3.920 $ -3.45% 858,134
12/06/26 4.060 $ +3.84% 1,005,270
11/06/26 3.910 $ -7.57% 1,298,951
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.120USD
Average target price
4.000USD
Spread / Average Target
-2.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!